Allena Pharmaceuticals
Philip Ochola serves as the Managing Partner at Mindset Consulting, LLC, since December 2019, specializing in marketing clinical operation seminars, conducting training needs analysis, and delivering course presentations. Additionally, Philip holds the position of Clinical Trials Associate at Allena Pharmaceuticals, Inc., beginning in 2018, where responsibilities include planning, executing, and managing clinical trials for Enteric Oxaluria/Stone Kidney Disease, encompassing various aspects of clinical research from study start-up through study completion. Philip earned a Bachelor's degree from the University of Nairobi, Kenya.
Allena Pharmaceuticals
Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney. The company is focused on metabolic disorders that result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease, or CKD, and end-stage renal disease.